Ray, A
Das, D S
Song, Y
Hideshima, T
Tai, Y-T
Chauhan, D
Anderson, K C
Article History
First Online: 6 November 2017
Competing interests
: KCA is an advisor for Celgene, Millennium Pharmaceuticals and Gilead Sciences, and is a Scientific Founder of OncoPep and C4 therapeutics. Other authors have no competing financial interests.